The company is a specialty chemicals manufacturer with a product portfolio focused on acetone and phosphorus-based chemicals and their derivatives. The company serves multiple industrial applications and has been expanding its product portfolio towards higher-value derivatives.
The shares of Prasol Chemicals are currently trading at Rs. 838.00, up by 9.71%. The company has a market capitalization of Rs. 4,960.16 crore. The stock’s 52 week high is Rs. 840.15 and its 52 week low is Rs. 601.00. The stock has recently launched the ipo and has delivered a negative listing gain of -1.92%.
What’s The News?
Prasol Chemicals reported a strong set of Q1 FY27 financial results, with both revenue and profitability showing significant year-on-year growth. Revenue from operations stood at Rs. 433.6 crore, compared with around Rs. 319.6 crore in Q1 FY26, representing growth of approximately 35.7% YoY. EBITDA increased to Rs. 90.3 crore, compared with around Rs. 40 crore in the corresponding quarter, while EBITDA margin expanded to approximately 20.8%. Profit after tax stood at Rs. 61 crore, compared with Rs. 24.3 crore in Q1 FY26, marking a growth of around 151% YoY.
Prasol Chemicals Q1 FY27 Financial Performance
Looking at the quarterly results of Prasol Chemicals Ltd, the company’s revenue from operations stood at Rs. 433.65 crore in Q1 FY27, compared with Rs. 319.56 crore in Q1 FY26, registering a growth of around 35.70% YoY. On a sequential basis, revenue increased by around 29.45% QoQ from Rs. 335.00 crore in Q4 FY26.
In Q1 FY27, the company’s net profit stood at Rs. 61.02 crore, compared with Rs. 24.34 crore in Q1 FY26, registering a sharp growth of around 150.70% YoY. On a QoQ basis, net profit increased by around 205.10% from Rs. 20.00 crore in Q4 FY26. The company’s basic EPS stood at Rs. 10.52 in Q1 FY27, compared with Rs. 4.20 in Q1 FY26 and Rs. 3.42 in Q4 FY26.
Improvement in Operations
One of the key factors cited by the company for its good performance during the quarter was an increase in efficiency witnessed at its Mahad manufacturing plant, where apparently record levels of production were attained.
Prasol Chemicals’ margins were aided further by changes made in the product mix in its acetone and phosphorus value chains where there was a greater focus on more profitable secondary and tertiary derivatives.
It should however be noted that the company has also hinted that the unusually high margin seen during the quarter might not be entirely sustainable. The margins have been influenced by geopolitical changes and currency movements.
FY27 Revenue and EBITDA Guidance
For FY27, Prasol Chemicals Ltd expects to achieve revenue in the range of Rs. 1,550 crore to Rs. 1,650 crore. The company has also guided for EBITDA of Rs. 240 crore to Rs. 250 crore during the financial year.
These figures represent the management’s guidance for FY27 and are not reported financial results. The company’s ability to achieve these targets will depend on factors including demand conditions, product realisations, operating performance and the broader market environment.
Expansion Strategy
The first phase of the expansion is aimed at strengthening existing product capacities and is expected to generate an additional Rs. 500–550 crore of revenue over two years, according to management’s stated plans. The second phase is focused on new products emerging from the company’s R&D efforts, with spending expected to begin from the second half of FY28.
Investor Perspective
In the first quarter of FY27, Prasol Chemicals witnessed a robust growth in revenues accompanied by an even more pronounced growth in profits. The main things to look out for in the future would include the sustainability of the high level of EBITDA margins, and the accomplishment of the company’s expansion plans along with hitting the revenue and EBITDA target for FY27.
The long-term target of Rs. 2,800-3,000 crore revenue is quite evident but the accomplishment of the target would depend on successful expansion of the company along with the product demand and development.